Sboll is Your Go-to Source for the Latest Finance News, Covering Markets, Banking, Investments, Economy and Stocks.
⎯ 《 Sboll • Com 》

List of All Articles with Tag '4523 jp'

Eisai Alzheimer Drug Shows Promise in Injected-At-Home Form
Eisai Alzheimer Drug Shows Promise in Injected-At-Home Form
An experimental version of Eisai Co.’s Alzheimer’s drug that might be given in patients’ homes exceeded the power
2023-10-26 08:28
Novartis Spinoff Sandoz to Start Trading as Standalone Drugmaker
Novartis Spinoff Sandoz to Start Trading as Standalone Drugmaker
Sandoz Group AG, the maker of copycat medicines, was spun off from drugmaker Novartis AG to begin life
2023-10-04 16:17
Eisai’s Alzheimer’s Drug Wins Approval in Japan, Following US
Eisai’s Alzheimer’s Drug Wins Approval in Japan, Following US
Eisai Co.’s breakthrough Alzheimer’s disease drug won clearance from Japanese regulators after the medicine was fully cleared in
2023-09-25 14:26
Eisai Azheimer’s Drug Set to Win Japanese Approval, Following US
Eisai Azheimer’s Drug Set to Win Japanese Approval, Following US
Eisai Co.’s breakthrough Alzheimer’s disease drug is poised to gain the backing of Japanese regulators after the medicine
2023-08-21 21:28
China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US
China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US
As drugmakers in the US steel for price negotiations ushered in by President Joe Biden’s Inflation Reduction Act,
2023-08-03 10:29
Medicare Proposes Expanding Patient Access to Alzheimer’s Scans
Medicare Proposes Expanding Patient Access to Alzheimer’s Scans
The US Medicare program will roll back rules that limited coverage for an expensive imaging scan for people
2023-07-18 06:25
Lilly Applies for Alzheimer’s Drug’s US Approval After Trial Success
Lilly Applies for Alzheimer’s Drug’s US Approval After Trial Success
Eli Lilly & Co. said it applied for full US approval of its Alzheimer’s disease drug that’s expected
2023-07-17 22:51
Eisai Appoints CEO’s 34-Year-Old Son to Lead Global Alzheimer Drug Program
Eisai Appoints CEO’s 34-Year-Old Son to Lead Global Alzheimer Drug Program
Japanese drug giant Eisai Co. said global Alzheimer drug program officer Ivan Cheung will retire at the end
2023-07-11 09:56
How a Japanese Drugmaker Clinched Win Over Alzheimer’s
How a Japanese Drugmaker Clinched Win Over Alzheimer’s
(This story was originally published Sept. 29. On Thursday, the US Food and Drug Administration granted full approval
2023-07-07 08:46
Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move expected to widen access to
2023-07-07 05:16
Eisai, Biogen Clinch FDA Advisers’ Support for Alzheimer’s Drug
Eisai, Biogen Clinch FDA Advisers’ Support for Alzheimer’s Drug
Eisai Co.’s Alzheimer’s disease drug developed with Biogen Inc. gained support from advisers to US regulators, paving the
2023-06-12 09:28
AstraZeneca’s Japan Partner to Go Solo on Future Cancer Drugs
AstraZeneca’s Japan Partner to Go Solo on Future Cancer Drugs
When Japanese pharmaceutical company Daiichi Sankyo Co. discovered a groundbreaking cancer treatment, it turned to bigger Western drugmaker
2023-06-07 05:28
«12»